Added 5 days ago Drug news
Analysis of phase III DECLARE-TIMI 58 trial showed that Farxiga reduced the risk of adverse CV events
Positive results from a pre-specified sub-analysis of the Phase III DECLARE-TIMI 58 trial showed that Farxiga (dapagliflozin) from AstraZeneca, reduced...
Added 7 days ago Drug news
The European Commission (EC) has approved a new indication for Praluent (alirocumab), from Sanofi + Regeneron, to reduce cardiovascular (CV)...
Added 1 month ago Drug news
CHMP recommends Praluent to reduce risk of established atherosclerotic cardiovascular disease. Sanofi + Regeneron
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Praluent (alirocumab),...
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
The Cardiovascular Metabolism Knowledge Centre is an information hub providing expert insight into the management of hypertension and type 2 diabetes. This Knowledge Centre contains a wealth of scientific video content offering insights and opinion from some of the leading experts in the field.
ESICM LIVES Congress 2018: Bringing you the latest news and insights from the 31st ESICM LIVES Congress, 20–24 October 2018 Paris, France.
See information on best practice in solid organ transplantation, and expert discussions on related hot topics.
Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients.
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
In light of the very recent consensus documents for the management of patients with VA released by the major international heart rhythm societies, the ESC Guidelines Committee decided to focus the content of this document on the prevention of SCD.
Added 3 years ago
Effect of 0.9% Saline or Plasma-Lyte 148 as Crystalloid Fluid Therapy in the Intensive Care Unit on Blood Product Use and Postoperative Bleeding After Cardiac Surgery
To evaluate the effect of Plasma-Lyte 148 (PL-148) compared with 0.9% saline (saline) on blood product use and postoperative bleeding in patients admitted to the intensive care unit (ICU) following cardiac surgery.
Added 9 months ago
Perioperative Use of Levosimendan Improves Clinical Outcomes in Patients Post-Cardiac Surgery: A Systematic Review and Meta-analysis.
Severe postoperative complications can affect cardiac surgery patients. Levosimendan is a novel calcium sensitizer commonly administered after cardiac surgery.
Added 10 months ago
Introduction: P2Y12 receptor antagonists, by inhibiting platelet activation and subsequent aggregation, are critical to prevent ischemic event recurrence after an...
Added 4 years ago
- Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
- Credits available
- Registration required
- Subscription fee